INS and Hypoglycemia: Furthermore, in vivo assessment in Sprague–Dawley rats showed that CS-PGA NPs produced an increase in cumulative hypoglycemia 1.7 times greater than standard subcutaneous insulin administration, likely owing to a sustained release of insulin that was more similar to the physiological pattern [149].